BioTechGrid – Page 2345

Fibrosis-focused Tvardi to go public via merger with cash-strapped Cara

December 18, 2024

Pruritus drug developer Cara Therapeutics kicked off the year halving its headcount, and the biotech has now found a new…

Biotechnology

Merck & Co. boosts GLP-1 portfolio by paying $112M upfront for Hansoh’s preclinical drug

December 18, 2024

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for…

Biotechnology

Aurion’s regenerative eye disease med improves vision in phase 1/2 trial

December 18, 2024

The highest dose of Aurion Biotech’s cell therapy, the main component of which recently received approval in Japan, has improved…

Biotechnology

Cognition’s phase 2 SHIMMER results finally allow dementia drug to shine

December 18, 2024

The failure of Cognition Therapeutics’ Alzheimer’s disease candidate CT1812 in the SHINE trial earlier this year may have rubbed off…

Genetics

Nvidia’s Venture Arm Raises Stake in AI Drug Discoverer Genesis Therapeutics

December 18, 2024

Evan Feinberg, PhD, founder and CEO of Genesis Therapeutics In the beginning, Genesis Therapeutics spun out from the Stanford University…

Genetics

How the Inflammatory Process Is Influenced by the Circadian Rhythm

December 18, 2024

There are various studies that have explored the role of the body’s circadian rhythm in regulating immune activity. Disruptions in…

Biotechnology

Novo Nordisk taps Photys for $186M cardiometabolic collab

December 17, 2024

With Novo Nordisk’s name already synonymous with treatments for diabetes and obesity, the Danish drugmaker has been making a concerted…

Biotechnology

Novo Holdings leads SiteOne’s $100M series C for non-opioid pain treatments

December 17, 2024

SiteOne Therapeutics is powering up with $100 million to advance its early pipeline of non-opioid therapeutics that target the peripheral…

Genetics

Ketamine Keeps Zebrafish from Giving up by Overstimulating Astroglia

December 17, 2024

The anesthetic ketamine could be a game changer for treating severe depression, but there are still many questions about how…

Medical Technology

BD, Babson Diagnostics expand fingertip blood draws to urgent care clinics, doctors’ offices

December 17, 2024

Longtime partners in simplifying blood sample collection and testing, BD and Babson Diagnostics are now making their miniaturized approach available…

Encrypted AI Training: Blockchain and Homomorphic Encryption Harden Federated Learning

Immunotherapy Reshapes Advanced Liver Cancer Care in Europe, but Access Lags Behind

Mother and Baby Do Not Share a Metabolic Fingerprint at Birth, Study Finds

Water Molecules Shield Metal-Organic Framework From Ibuprofen’s Strongest Grip

Liver Surgery Gives Cats With Rare Tumours a Far Better Prognosis Than Once Thought

Aging Blunts a Protective Gut Lipid Defense That Keeps COVID-19 Mild

Exploring the Future of Healthcare with Panos Karelis

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

Fibrosis-focused Tvardi to go public via merger with cash-strapped Cara

Merck & Co. boosts GLP-1 portfolio by paying $112M upfront for Hansoh’s preclinical drug

Aurion’s regenerative eye disease med improves vision in phase 1/2 trial

Cognition’s phase 2 SHIMMER results finally allow dementia drug to shine

Nvidia’s Venture Arm Raises Stake in AI Drug Discoverer Genesis Therapeutics

How the Inflammatory Process Is Influenced by the Circadian Rhythm

Novo Nordisk taps Photys for $186M cardiometabolic collab

Novo Holdings leads SiteOne’s $100M series C for non-opioid pain treatments

Ketamine Keeps Zebrafish from Giving up by Overstimulating Astroglia

BD, Babson Diagnostics expand fingertip blood draws to urgent care clinics, doctors’ offices

Siemens Healthineers and Novo team up on fatty liver disease awareness, testing

Cordis’ sirolimus drug-coated balloon earns FDA approval as a breakthrough device

Anaconda Biomed snares $56M in funding for endovascular tech

Medtronic earns FDA clearance for LigaSure use with its Hugo robotic system